1. Home
  2. PRQR vs SWIN Comparison

PRQR vs SWIN Comparison

Compare PRQR & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • SWIN
  • Stock Information
  • Founded
  • PRQR 2012
  • SWIN 2017
  • Country
  • PRQR Netherlands
  • SWIN Hong Kong
  • Employees
  • PRQR N/A
  • SWIN N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • PRQR Health Care
  • SWIN
  • Exchange
  • PRQR Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • PRQR 232.8M
  • SWIN 258.0M
  • IPO Year
  • PRQR 2014
  • SWIN 2023
  • Fundamental
  • Price
  • PRQR $2.25
  • SWIN $4.01
  • Analyst Decision
  • PRQR Strong Buy
  • SWIN
  • Analyst Count
  • PRQR 8
  • SWIN 0
  • Target Price
  • PRQR $8.88
  • SWIN N/A
  • AVG Volume (30 Days)
  • PRQR 319.5K
  • SWIN 733.0K
  • Earning Date
  • PRQR 08-07-2025
  • SWIN 06-30-2025
  • Dividend Yield
  • PRQR N/A
  • SWIN N/A
  • EPS Growth
  • PRQR N/A
  • SWIN N/A
  • EPS
  • PRQR N/A
  • SWIN N/A
  • Revenue
  • PRQR $20,129,184.00
  • SWIN $3,316,000.00
  • Revenue This Year
  • PRQR N/A
  • SWIN $29.79
  • Revenue Next Year
  • PRQR N/A
  • SWIN $54.60
  • P/E Ratio
  • PRQR N/A
  • SWIN N/A
  • Revenue Growth
  • PRQR 8.65
  • SWIN N/A
  • 52 Week Low
  • PRQR $1.07
  • SWIN $1.16
  • 52 Week High
  • PRQR $4.62
  • SWIN $5.09
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 57.03
  • SWIN 50.49
  • Support Level
  • PRQR $2.18
  • SWIN $3.45
  • Resistance Level
  • PRQR $2.33
  • SWIN $4.24
  • Average True Range (ATR)
  • PRQR 0.13
  • SWIN 0.42
  • MACD
  • PRQR 0.02
  • SWIN -0.09
  • Stochastic Oscillator
  • PRQR 84.91
  • SWIN 34.15

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

Share on Social Networks: